Universal Technical Institute Inc (UTI): who owns it and who trades it
As of Nov 16, 2026, UTI insiders reported 14 open-market sales worth $135M and 12 purchases worth $31.1M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Coliseum Capital Partners, L.P. (Director), with $124M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Universal Technical Institute
From the latest filingsOverall: more buying than selling. Famous investors mostly bought. Funds and insiders were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns UTI
262 funds and institutions reported UTI shares worth $2.7B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 13.7%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 7.55M | 13.72% | $323M | +108% |
| Congress Asset Management Co | 3.00M | 5.45% | $128M | +39% |
| T. Rowe Price Associates | 2.58M | 4.69% | $110M | +52% |
| Driehaus Capital Management LLC | 2.50M | 4.54% | $107M | +42% |
| California State Teachers Retirement System | 2.42M | 4.40% | $56.7M | +3504% |
| Vanguard Capital Management LLC | 2.21M | 4.02% | $94.6M | +2% |
| State Street Corp | 1.89M | 3.43% | $80.9M | +82% |
| Thrivent Financial for Lutherans | 1.65M | 3.00% | $70.7M | -8% |
| Hood River Capital Management LLC | 1.56M | 2.83% | $66.6M | -2% |
| Praetorian PR LLC | 1.35M | 2.45% | $57.7M | +35% |
| Wasatch Advisors LP | 1.30M | 2.35% | $55.5M | -34% |
| Dimensional Fund Advisors LP | 1.29M | 2.34% | $55.1M | -1% |
| American Century Companies Inc | 1.26M | 2.29% | $53.9M | -12% |
| Geode Capital Management, LLC | 1.24M | 2.25% | $53M | +6% |
| Royce & Associates LP | 1.20M | 2.18% | $51.2M | +16% |
| Conestoga Capital Advisors, LLC | 1.18M | 2.15% | $50.5M | -9% |
| First Eagle Investment Management, LLC | 1.14M | 2.07% | $48.8M | +142% |
| Needham Investment Management LLC | 1.13M | 2.05% | $48.3M | +10% |
| Punch & Associates Investment Management, Inc. | 1.10M | 1.99% | $46.9M | +2% |
| Alyeska Investment Group, L.P. | 1.08M | 1.95% | $46M | +19% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, UTI insiders reported $31.1M of open-market purchases and $135M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Robert Thomas Devincenzi | Director | Purchase | 1,000 | $19.68 | $19.7K | Form 4 |
| Sep 21, 2026 | Robert Thomas Devincenzi | Director | Purchase | 1,000 | $19.83 | $19.8K | Form 4 |
| Aug 27, 2026 | Robert Thomas Devincenzi | Director | Purchase | 1,000 | $21.80 | $21.8K | Form 4 |
| Aug 25, 2026 | Robert Thomas Devincenzi | Director | Purchase | 1,000 | $21.77 | $21.8K | Form 4 |
| Aug 12, 2026 | Robert Thomas Devincenzi | Director | Purchase | 1,000 | $25.95 | $25.9K | Form 4 |
| Aug 10, 2026 | Robert Thomas Devincenzi | Director | Purchase | 8,000 | $28.21 | $226K | Form 4 |
| Jun 29, 2026 | Jerome Alan Grant | CEO | Sale | 48,961 | $41.63 | $2M | Form 4 |
| Jun 29, 2026 | Jerome Alan Grant | CEO | Sale | 45,539 | $41.15 | $1.9M | Form 4 |
| Jun 22, 2026 | Kevin Prehn | President | Sale | 4,545 | $40.00 | $182K | Form 4 |
| Jun 8, 2026 | Coliseum Capital Partners, L.P. +4 | Director | Sale | 3.00M | $41.40 | $124M | Form 4 |
| Jun 5, 2026 | Christine Kline | Vice president | Sale | 3,500 | $44.42 | $155K | Form 4 |
| May 11, 2026 | Linda J Srere | Director | Sale | 15,000 | $36.59 | $549K | Form 4 |
| Mar 27, 2026 | Christopher E. Kevane | Vice president | Sale | 23,654 | $37.55 | $888K | Form 4 |
| Mar 17, 2026 | George W. Brochick | Director | Sale | 5,000 | $36.59 | $183K | Form 4 |
| Mar 6, 2026 | Shannon Lei Okinaka | Director | Sale | 10,000 | $34.74 | $347K | Form 4 |
| Mar 4, 2026 | Todd A Hitchcock | Vice president | Sale | 16,500 | $37.33 | $616K | Form 4 |
| Mar 2, 2026 | Sherrell Smith | Vice president | Sale | 22,671 | $37.10 | $841K | Form 4 |
| Mar 2, 2026 | Sherrell Smith | Vice president | Sale | 30,000 | $36.99 | $1.1M | Form 4 |
| Feb 27, 2026 | Jerome Alan Grant | CEO | Sale | 60,040 | $34.95 | $2.1M | Form 4 |
| Feb 13, 2026 | Carolyn Ann Frank | Vice president | Sale | 1,750 | $30.08 | $52.6K | Form 4 |
| Dec 5, 2025 | Coliseum Capital Management, LLC +4 | Director | Purchase | 191,830 | $25.38 | $4.9M | Form 4 |
| Dec 3, 2025 | Coliseum Capital Management, LLC +4 | Director | Purchase | 143,673 | $24.52 | $3.5M | Form 4 |
| Dec 3, 2025 | Coliseum Capital Management, LLC +4 | Director | Purchase | 211,563 | $25.01 | $5.3M | Form 4 |
| Dec 2, 2025 | Coliseum Capital Management, LLC +4 | Director | Purchase | 467,020 | $24.40 | $11.4M | Form 4 |
| Dec 1, 2025 | Coliseum Capital Management, LLC +4 | Director | Purchase | 171,430 | $23.66 | $4.1M | Form 4 |
| Dec 1, 2025 | Coliseum Capital Management, LLC +4 | Director | Purchase | 69,657 | $24.11 | $1.7M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Coliseum Capital Partners, L.P. | Director | – | $124M | Jun 8, 2026 |
| Coliseum Capital Management, LLC | Director | $30.8M | – | Dec 5, 2025 |
| Jerome Alan Grant | Chief Executive Officer, Director | – | $6M | Jun 29, 2026 |
| Sherrell Smith | EVP, Chief Academic Officer | – | $2M | Mar 2, 2026 |
| Christopher E. Kevane | EVP and Chief Legal Officer | – | $888K | Mar 27, 2026 |
| Todd A Hitchcock | EVP/COO | – | $616K | Mar 4, 2026 |
| Linda J Srere | Director | – | $549K | May 11, 2026 |
| Shannon Lei Okinaka | Director | – | $347K | Mar 6, 2026 |
| Robert Thomas Devincenzi | Director | $335K | – | Sep 28, 2026 |
| George W. Brochick | Director | – | $183K | Mar 17, 2026 |
| Kevin Prehn | Concorde Division President | – | $182K | Jun 22, 2026 |
| Christine Kline | Senior Vice President and CAO | – | $155K | Jun 5, 2026 |
| Carolyn Ann Frank | SVP/Chief HR Officer | – | $52.6K | Feb 13, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
UTI short interest
High short interest. 14.0% of UTI shares are sold short: about 1 share in 7. Over the last 12 reports the number of shares short went up 134%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 7.69M UTI shares were sold short, 14.0% of the shares outstanding, up 12.7% from the report before. At the average daily volume of 1.39M shares, buying them all back would take about 5.5 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 7.69M | 13.96% | +13% | 1.39M | 5.5 |
| Oct 15, 2026 | 6.82M | 12.39% | -2% | 1.37M | 5.0 |
| Sep 30, 2026 | 6.93M | 12.59% | +11% | 2.18M | 3.2 |
| Sep 15, 2026 | 6.26M | 11.37% | +14% | 1.56M | 4.0 |
| Aug 31, 2026 | 5.49M | 9.96% | +8% | 1.80M | 3.0 |
| Aug 14, 2026 | 5.06M | 9.19% | +15% | 2.24M | 2.3 |
| Jul 31, 2026 | 4.40M | 7.98% | -4% | 939,861 | 4.7 |
| Jul 15, 2026 | 4.60M | 8.35% | -3% | 980,022 | 4.7 |
| Jun 30, 2026 | 4.75M | 8.63% | +1% | 891,852 | 5.3 |
| Jun 15, 2026 | 4.71M | 8.56% | -12% | 1.45M | 3.2 |
| May 29, 2026 | 5.38M | 9.77% | +63% | 2.10M | 2.6 |
| May 15, 2026 | 3.29M | 5.98% | +17% | 902,228 | 3.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Universal Technical Institute company events
Universal Technical Institute filed 8 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Aug 18, 2026.
- Aug 18, 2026AgreementNew Secured Revolving Credit Facility. Filing
- Aug 5, 2026ResultsReleased financial results. Filing
- May 6, 2026ResultsReleased financial results. Filing
- Mar 18, 2026VoteReported shareholder vote results. Filing
- Mar 17, 2026RulesChanged its code of ethics. Filing
- Feb 4, 2026ResultsReleased financial results. Filing
- Nov 19, 2025ResultsReleased financial results. Filing
- Nov 18, 2025AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Universal Technical Institute financials
Famous investors that hold UTI
5 of the 50 well-known investors we track reported holding UTI in their latest 13F filing. The largest position is Steve Cohen's, worth $25.5M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Steve Cohen · Point72 Asset Management | Q3 2026 | 1.37M | $25.5M | 0.0% | +69% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 734,651 | $13.7M | 0.0% | New |
| Jim Simons · Renaissance Technologies | Q3 2026 | 205,259 | $3.8M | 0.0% | -57% |
| Israel Englander · Millennium Management | Q3 2026 | 202,268 | $3.8M | 0.0% | New |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 123,203 | $2.3M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named UTI in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 13, 2026 | Capital International Investors | 13G | 8.0% |
| Nov 13, 2026 | Capital International Investors | 13G | 8.0% |
| Oct 27, 2026 | BlackRock, Inc. | 13G/A | 14.0% |
| Oct 27, 2026 | BlackRock, Inc. | 13G/A | 14.0% |
Questions about Universal Technical Institute Inc (UTI) stock
Who owns the most UTI stock?
The largest reported owner of Universal Technical Institute Inc (UTI) is BlackRock, Inc., with 13.7% of the company. In total, 262 funds and institutions reported holding UTI at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are UTI insiders buying or selling?
In the last 12 months, UTI insiders reported 12 open-market purchases worth $31.1M and 14 sales worth $135M. The latest trade was on Sep 28, 2026. See every trade.
What is the short interest in UTI?
As of Oct 30, 2026, 7.69M UTI shares were sold short, 14.0% of the shares outstanding, up 12.7% from the report before. At the average daily volume of 1.39M shares, buying them all back would take about 5.5 trading days (days to cover). See the history.
Which famous investors hold UTI?
5 of the 50 well-known investors we track reported UTI in their latest 13F filing, including Steve Cohen, Ken Griffin, Jim Simons. The largest position is worth $25.5M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.